Home / Musculoskeletal system / Ibandronic Acid
ATC M05BA06 · Drugs for Treatment of Bone Diseases
Ibandronic Acid shortage
As of 31 Oct 2026, Ibandronic Acid has a reported shortage in 2 of the 5 countries we track (Italy, Spain), covering 9 products.
Countries2/5
Products9packs or presentations
Short since30 Nov 20223.9 years ago
Earliest returnnot givencompany estimate
No return date9products
Main reasonManufacturing problem
Timeline
ItalySpain
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | ACIDO IBANDRONICO ZENTIVA | ZENTIVA ITALIA S.R.L. | 30 Nov 2022 | not given | Manufacturing problem Problemi produttivi |
| IT | ACIDO IBANDRONICO MYLAN | MYLAN S.P.A. | 9 Dec 2024 | not given | Manufacturing problem Problemi produttivi |
| IT | ACIDO IBANDRONICO SANDOZ | SANDOZ S.P.A. | 24 Jul 2025 | not given | Manufacturing problem Problemi produttivi |
| IT | ACIDO IBANDRONICO ALTER | LABORATORI ALTER S.R.L. | 23 Nov 2025 | not given | Increased demand Elevata richiesta/problemi produttivi |
| IT | ACIDO IBANDRONICO ACCORD | ACCORD HEALTHCARE, S.L.U. | 28 Jul 2026 | not given | Manufacturing problem Problemi produttivi |
| ES | ACIDO IBANDRONICO VIATRIS 150 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 3 comprimidos | Viatris Limited | 12 Dec 2024 | not given | Not stated |
| ES | ACIDO IBANDRONICO VIATRIS 150 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 1 comprimido | Viatris Limited | 19 Dec 2024 | not given | Not stated |
| ES | ACIDO IBANDRONICO SANDOZ 150 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG 1 comprimido | Sandoz Farmaceutica S.A. | 29 May 2025 | not given | Not stated |
| ES | ACIDO IBANDRONICO SANDOZ 150 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG 3 comprimidos | Sandoz Farmaceutica S.A. | 29 May 2025 | not given | Not stated |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.